UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000061311
Receipt number R000070155
Scientific Title Rethinking B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in hemodialysis patients
Date of disclosure of the study information 2026/04/19
Last modified on 2026/04/19 22:28:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Rethinking B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in hemodialysis patients

Acronym

Rethinking of natriuretic peptides in h0emodialysis patients

Scientific Title

Rethinking B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in hemodialysis patients

Scientific Title:Acronym

Rethinking of natriuretic peptides in h0emodialysis patients

Region

Japan


Condition

Condition

168 patients undergoing maintenance hemodialysis, 75 had not received sacubitril/valsartan, while 93 had been receiving the same medication for at least 3 months.

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Correlation between BNP and NT-proBNP according to the presence or absence of sacubitril/valsartan therapy, and changes in BNP and NT-proBNP before and after hemodialysis.

Basic objectives2

Others

Basic objectives -Others

None.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

1.To examine whether a positive correlation between BNP and NT-proBNP is observed according to the presence or absence of sacubitril/valsartan therapy, and whether a similar correlation is maintained irrespective of its administration. 2.To determine, based on changes in BNP and NT-proBNP before and after hemodialysis, whether measurements in hemodialysis patients should be interpreted using pre-dialysis or post-dialysis values.

Key secondary outcomes

None.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

A patient undergoing maintenance hemodialysis three times a week at Fujita Memorial Hospital.

Key exclusion criteria

Patients who have been taking sacubitril/valsartan for less than 3 months.

Target sample size

168


Research contact person

Name of lead principal investigator

1st name Ryoichi
Middle name
Last name Miyazaki

Organization

Fujita Memorial Hospital

Division name

Iternal Medicine

Zip code

910-0004

Address

4-15-7, Houei, Fukui, Fukui City

TEL

0776211277

Email

ryoichi@mitene.or.jp


Public contact

Name of contact person

1st name RYOICHI
Middle name
Last name MIYAZAKI

Organization

Fujita Memorial Hospital

Division name

Iternal Medicine

Zip code

910-0004

Address

4-15-7, Houei, Fukui City

TEL

0776211277

Homepage URL

http://www.fujita-mhp.jp/

Email

ryoichi@mitene.or.jp


Sponsor or person

Institute

Fujita Memorial Hospital

Institute

Department

Personal name

RYOICHI MIYAZAKI


Funding Source

Organization

Fujita Memorial Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

None.

Name of secondary funder(s)

None.


IRB Contact (For public release)

Organization

Fujita Memorial Hospital

Address

4-15-7, Houei, Fukui City

Tel

0776211277

Email

ryoichi@mitene.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

SELECT


Institutions

Institutions

藤田記念病院


Other administrative information

Date of disclosure of the study information

2026 Year 04 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications

https://link.springer.com/journal/41100/articles

Number of participants that the trial has enrolled

168

Results

1. Regardless of whether sacubitril/valsartan was administered, BNP and NT-proBNP showed a positive correlation, and there was no significant difference in the correlation coefficient.
2. Both BNP and NT-proBNP levels decreased significantly during dialysis; however, there was no correlation between the degree of decrease in either BNP or NT-proBNP and the amount of weight loss during dialysis.

Results date posted

2026 Year 04 Month 19 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2026 Year 10 Month 30 Day

Baseline Characteristics

Patients undergoing hemodialysis three times a week at Fujita Memorial Hospital

Participant flow


Adverse events

None.

Outcome measures

The correlation between BNP and NT-proBNP after dialysis, and the relationship between Log(NT-proBNP) and various echocardiographic parameters

Plan to share IPD

No plans to share.

IPD sharing Plan description

No plans to share.


Progress

Recruitment status

Completed

Date of protocol fixation

2025 Year 07 Month 15 Day

Date of IRB

2025 Year 04 Month 01 Day

Anticipated trial start date

2025 Year 08 Month 01 Day

Last follow-up date

2026 Year 03 Month 10 Day

Date of closure to data entry

2026 Year 04 Month 09 Day

Date trial data considered complete

2026 Year 04 Month 10 Day

Date analysis concluded

2026 Year 04 Month 15 Day


Other

Other related information

None.


Management information

Registered date

2026 Year 04 Month 19 Day

Last modified on

2026 Year 04 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070155